デフォルト表紙
市場調査レポート
商品コード
1433622

デジタルパソロジーの市場規模、シェア、動向分析レポート:製品別、タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Digital Pathology Market Size, Share & Trends Analysis Report By Application (Academic Research, Disease Diagnosis), By Product (Software, Device), By Type, By End-use (Diagnostic Labs, Hospitals), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
デジタルパソロジーの市場規模、シェア、動向分析レポート:製品別、タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年01月24日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルパソロジー市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のデジタルパソロジー市場規模は、2024年から2030年にかけてCAGR 8.0%を記録し、2030年には17億3,000万米ドルに達すると予測されています。

同市場は、正確な診断に対する需要の高まりに後押しされた慢性疾患の有病率の上昇により、飛躍的な成長が見込まれています。慢性疾患は成人のほぼ3人に1人が罹患しています。CDCによると、米国では成人の約51.8%が少なくとも1つの慢性疾患を抱えています。分子組織プロファイリング、バイオバンク、組織マイクロアレイ解析、分子生物学を含むデジタルパソロジーは、医薬品開発パイプラインやコンパニオン診断において重要な役割を果たしています。組織ベースのバイオマーカー研究における高品質な組織サンプルの需要の高まりが、予測期間中の技術採用を促進すると予想されます。

2022年6月にTribun Health社が患者に臨床的かつタイムリーな専門知識を提供するために使用されるオンライン遠隔病理学プラットフォームであるTeleSlide Patho 5を発売するなど、技術の新バージョンの発売により遠隔病理学の採用が増加しています。さらに、各社が競争により厳しい戦略を採用するため、市場は近い将来に激しい競争に見舞われると予想されます。さらに、病理検査室のデジタル化などの技術進歩は、専門性をより効率的にし、検体の再現性を高め、病理医の作業を容易にします。ここ数年、いくつかの画期的な進歩が市場の成長を大きく後押ししています。

例えば、2021年9月、ペイジは前立腺がん検出用AIソリューション「ペイジ・プロステート」のFDA承認を取得しました。同製品は、販売承認を取得した最初のAI対応病理製品です。これに続き、2021年10月にはF.ホフマン・ラ・ロシュ社とアイベックスが、患者ケアの向上を目的とした人工知能ベースの病理学用途の開発で提携しました。さらに、主要プレーヤーは、デジタルパソロジーの採用を強化するために、ロボット光顕微鏡、デジタル画像処理、複数の光ファイバー通信、コンピュータ化などの技術的進歩に焦点を当てた協働やパートナーシップのような戦略を採用しています。

例えば、2022年12月、Deciphex社は、研究病理医が利用可能なツールに革命を起こすことを目的とし、ユーザーが関連データとサンプルを効果的に管理できるLIMSソフトウェアの限界を克服するように設計されたデジタル研究病理学プラットフォームであるPatholytix 3.0を発売しました。さらに同社は、ワークフローに影響を与え、よりシンプルで迅速なレポート作成を可能にする新プラットフォームの特徴も発表しました。

デジタル病理市場レポートハイライト

  • 製品別では、デバイスセグメントが2023年に51.72%の最大シェアを占め、予測期間中に有利な成長率で成長すると予測されています。デバイスセグメントには、スライド管理システムとスキャナが含まれます。このセグメントの成長は、解像度を高めた学術研究活動におけるデジタルパソロジーの採用増加によるものです。
  • 用途別では、疾病診断が、慢性疾患の有病率の増加と高貴な診断技術への需要により、2024年から2030年にかけて最も速い成長率を示すと予測されています。
  • 最終用途別では、効率的な疾患診断のために医療環境でのデジタル病理診断の導入が進んでいることから、2023年には病院セグメントが36.7%のシェアで市場を独占しました。
  • 北米は、確立されたデジタルインフラが存在し、医療環境への技術導入に関連するいくつかの技術的進歩があるため、2023年には40.7%のシェアで市場全体を支配しました。

目次

第1章 デジタルパソロジー市場:調査手法と範囲

第2章 デジタルパソロジー市場:エグゼクティブサマリー

  • 市場スナップショット
  • セグメントスナップショット
  • 競合考察のスナップショット

第3章 デジタルパソロジー市場:変数、動向、および範囲

  • 市場系統の見通し
  • デジタルパソロジー市場-市場力学
  • デジタルパソロジー市場分析ツール:ポーターのファイブフォース分析
  • PESTLE分析
  • 技術トレンド分析
  • 規制の枠組み
  • コスト構造分析
  • ユーザー視点の分析
  • ケーススタディ
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 デジタルパソロジー市場:製品の推定・動向分析

  • デジタルパソロジー市場:製品別、重要なポイント
  • デジタルパソロジー市場:製品の動向と市場シェア分析、2022年と2030年
  • ソフトウェア
  • デバイス
  • ストレージシステム

第5章 デジタルパソロジー市場:タイプの推定・動向分析

  • デジタルパソロジー市場:タイプ別、重要なポイント
  • デジタルパソロジー市場:タイプの動向と市場シェア分析、2022年と2030年
  • 獣医用
  • ヒト用

第6章 用途の推定・動向分析

  • デジタルパソロジー市場:用途別、重要なポイント
  • デジタルパソロジー市場:用途の動向と市場シェア分析、2022年と2030年
  • 創薬・開発
  • 学術研究
  • 疾患診断

第7章 デジタルパソロジー市場:最終用途の推定・動向分析

  • デジタルパソロジー市場:最終用途別、重要なポイント
  • デジタルパソロジー市場:最終用途の動向と市場シェア分析、2022年と2030年
  • 病院
  • バイオテクノロジー企業・製薬企業
  • 診断ラボ
  • 学術・研究機関

第8章 デジタルパソロジー市場:国の推定・動向分析

  • デジタルパソロジー市場:地域の動向分析、2022年と2030年

第9章 競合情勢

  • 企業の分類
  • 競合市場の参入戦略
  • 国/地域別の非公開会社/ベンダー
  • 企業の市場シェア分析、2023年
  • 戦略マッピング
  • 企業プロファイル/リスト
    • Leica Biosystems Nussloch GmbH(Danaher)
    • Hamamatsu Photonics, Inc
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd
    • Mikroscan Technologies, Inc
    • Inspirata, Inc.
    • Epredia(3DHISTECH Ltd.)
    • Visiopharm A/S
    • Huron Technologies International Inc.
    • ContextVision AB
    • CellaVision
    • Hangzhou Zhiwei Information Technology Co. Ltd.(Morphogo)
    • West Medica Produktions-und Handels-GmbH(West Medica)
    • aetherAI
    • Ibex(Ibex Medical Analytics)
    • SigTuple Technologies Private Limited
    • Morphle Labs, Inc
    • Bionovation Biotech, Inc
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Digital Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 21 Europe Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 25 Europe Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 26 UK Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 UK Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 UK Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 UK Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 34 France Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 France Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 France Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 France Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 38 Italy Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 Italy Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Italy Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 42 Spain Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Spain Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Spain Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 50 Norway Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Norway Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Norway Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 53 Norway Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 63 Japan Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 Japan Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Japan Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Japan Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 67 China Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 China Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 China Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 China Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 71 India Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 India Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 India Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 India Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 75 South Korea Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 South Korea Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 78 South Korea Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 Australia Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 81 Australia Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Australia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 83 Thailand Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Thailand Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 85 Thailand Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Thailand Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 87 Latin America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 92 Brazil Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 96 Argentina Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Argentina Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 98 Argentina Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 99 Argentina Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 100 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 101 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 102 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 103 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East and Africa Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East and Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East and Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 107 Middle East and Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East and Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 119 UAE Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Digital Pathology Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's Five Forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Digital pathology market: Product movement analysis
  • Fig. 17 Digital pathology market: Product segment dashboard
  • Fig. 18 Digital pathology market product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Digital pathology market: Type movement analysis
  • Fig. 25 Digital pathology market: Type segment dashboard
  • Fig. 26 Digital pathology market type outlook: Key takeaways
  • Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Digital pathology market: Application movement analysis
  • Fig. 30 Digital pathology market: Application segment dashboard
  • Fig. 31 Digital pathology market application outlook: Key takeaways
  • Fig. 32 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Digital pathology market: End-use movement analysis
  • Fig. 36 Digital pathology market: End-use segment dashboard
  • Fig. 37 Digital pathology market end-use outlook: Key takeaways
  • Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 Europe, SWOT
  • Fig. 47 Asia Pacific, SWOT
  • Fig. 48 Latin America, SWOT
  • Fig. 49 Middle East and Africa, SWOT
  • Fig. 50 North America
  • Fig. 51 North America Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S.
  • Fig. 53 U.S. Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 54 Canada
  • Fig. 55 Canada Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe
  • Fig. 57 Europe Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 58 UK
  • Fig. 59 UK Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 60 Germany
  • Fig. 61 Germany Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 62 Spain
  • Fig. 63 Spain Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 64 France
  • Fig. 65 France Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy
  • Fig. 67 Italy Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark
  • Fig. 69 Denmark Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 70 Norway
  • Fig. 71 Norway Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 72 Sweden
  • Fig. 73 Sweden Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan
  • Fig. 77 Japan Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 78 China
  • Fig. 79 China Digital Pathology market, 2018 - 2030 (USD Million)
  • Fig. 80 India
  • Fig. 81 India Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea
  • Fig. 83 South Korea Digital Pathology market, 2018 - 2030 (USD Million)
  • Fig. 84 Australia
  • Fig. 85 Australia Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 86 Thailand
  • Fig. 87 Thailand Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 88 Latin America
  • Fig. 89 Latin America Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 90 Brazil
  • Fig. 91 Brazil Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 92 Mexico
  • Fig. 93 Mexico Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 94 Argentina
  • Fig. 95 Argentina Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 96 Middle East and Africa
  • Fig. 97 MEA Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 98 South Africa
  • Fig. 99 South Africa Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 100 Saudi Arabia
  • Fig. 101 Saudi Arabia Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 102 UAE
  • Fig. 103 UAE Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 104 Kuwait
  • Fig. 105 Kuwait Digital pathology market, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-386-7

Digital Pathology Market Growth & Trends:

The global digital pathology market size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

Digital Pathology Market Report Highlights:

  • Based on product, The device segment held the largest share of 51.72% in 2023 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
  • Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2024 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
  • In terms of end-use, The hospitals segment dominated the market in 2023 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
  • North America dominated overall market in 2023 with a share of 40.7%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings

Table of Contents

Chapter 1. Digital Pathology Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database:
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research:
    • 1.3.5. Details Of Primary Research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for Primary Interviews in Europe
      • 1.3.5.3. Data for Primary Interviews in APAC
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Top down market estimation
    • 1.6.3. CAGR Calculation
    • 1.6.4. Key Report Updates
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Report Objectives
    • 1.9.1. Objective - 1
    • 1.9.2. Objective - 2

Chapter 2. Digital Pathology Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Digital Pathology Market: Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Digital Pathology Market- Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence Of Chronic Diseases
      • 3.2.1.2. Rapid Technological Advancement
      • 3.2.1.2.1. AI integration
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack Of Reimbursement For Digital Pathology-Enabled Services
      • 3.2.2.2. Lack of Skilled Professionals
    • 3.2.3. Industry Challenges
  • 3.3. Digital Pathology Market Analysis Tools: Porters
  • 3.4. PESTLE Analysis
  • 3.5. Technology Trend Analysis
  • 3.6. Regulatory Framework
  • 3.7. Cost Structure Analysis
  • 3.8. User Perspective Analysis
  • 3.9. Case Studies
  • 3.10. COVID 19 Impact

Chapter 4. Digital Pathology Market: Product Type Estimates & Trend Analysis

  • 4.1. Digital Pathology Market, Product Type: Key Takeaways
  • 4.2. Digital Pathology Market: Product Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Software
    • 4.3.1. Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.2. Integrated Software
      • 4.3.2.1. Integrated Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.3. Standalone Software
      • 4.3.3.1. Standalone Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Devices
    • 4.4.1. Devices Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Scanners
      • 4.4.2.1. Scanners market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.4.2.2. Brightfield Scanners
      • 4.4.2.2.1. Brightfield Scanners market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.4.2.3. Fluroscence Scanners
      • 4.4.2.3.1. Fluroscence Scanners market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.4.2.4. Others
      • 4.4.2.4.1. Others Scanner market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.3. Slide Management System
      • 4.4.3.1. Slide management system market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Storage Systems
    • 4.5.1. Storage Systems Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Digital Pathology Market: Type Estimates & Trend Analysis

  • 5.1. Digital Pathology Market, by Type: Key Takeaways
  • 5.2. Digital Pathology Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Veterinary Pathology
    • 5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Human Pathology
    • 5.4.1. Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Application Estimates & Trend Analysis

  • 6.1. Digital Pathology Market, Application Type: Key Takeaways
  • 6.2. Digital Pathology Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Drug Discovery & Development
    • 6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Academic Research
    • 6.4.1. Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Disease Diagnosis
    • 6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Cancer Cell Detection
      • 6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Others
      • 6.5.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Digital Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. Digital Pathology Market, By End Use: Key Takeaways
  • 7.2. Digital Pathology Market: End Use Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Biotech & Pharma Companies
    • 7.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Diagnostics Labs
    • 7.5.1. Diagnostics Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Digital Pathology Market: Country Estimates & Trend Analysis

  • 8.1 Digital Pathology Market: Regional Movement Analysis, 2022 & 2030
    • 8.1.1 North America
      • 8.1.1.1 North America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.1.2 U.S.
      • 8.1.1.2.1 Key Country Dynamics
      • 8.1.1.2.2 Competitive Scenario
      • 8.1.1.2.3 Regulatory Framework
      • 8.1.1.2.4 Reimbursement Scenario
      • 8.1.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.1.3 Canada
      • 8.1.1.3.1 Key Country Dynamics
      • 8.1.1.3.2 Competitive Scenario
      • 8.1.1.3.3 Regulatory Framework
      • 8.1.1.3.4 Reimbursement Scenario
      • 8.1.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.1.2 Europe
      • 8.1.2.1 Europe Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.2 UK
      • 8.1.2.2.1 Key Country Dynamics
      • 8.1.2.2.2 Competitive Scenario
      • 8.1.2.2.3 Regulatory Framework
      • 8.1.2.2.4 Reimbursement Scenario
      • 8.1.2.2.5 UK Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.3 Germany
      • 8.1.2.3.1 Key Country Dynamics
      • 8.1.2.3.2 Competitive Scenario
      • 8.1.2.3.3 Regulatory Framework
      • 8.1.2.3.4 Reimbursement Scenario
      • 8.1.2.3.5 Germany Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.4 France
      • 8.1.2.4.1 Key Country Dynamics
      • 8.1.2.4.2 Competitive Scenario
      • 8.1.2.4.3 Regulatory Framework
      • 8.1.2.4.4 Reimbursement Scenario
      • 8.1.2.4.5 France Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.5 Italy
      • 8.1.2.5.1 Key Country Dynamics
      • 8.1.2.5.2 Competitive Scenario
      • 8.1.2.5.3 Regulatory Framework
      • 8.1.2.5.4 Reimbursement Scenario
      • 8.1.2.5.5 Italy Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.6 Spain
      • 8.1.2.6.1 Key Country Dynamics
      • 8.1.2.6.2 Competitive Scenario
      • 8.1.2.6.3 Regulatory Framework
      • 8.1.2.6.4 Reimbursement Scenario
      • 8.1.2.6.5 Spain Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.7 Denmark
      • 8.1.2.7.1 Key Country Dynamics
      • 8.1.2.7.2 Competitive Scenario
      • 8.1.2.7.3 Regulatory Framework
      • 8.1.2.7.4 Reimbursement Scenario
      • 8.1.2.7.5 Denmark Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.8 Sweden
      • 8.1.2.8.1 Key Country Dynamics
      • 8.1.2.8.2 Competitive Scenario
      • 8.1.2.8.3 Regulatory Framework
      • 8.1.2.8.4 Reimbursement Scenario
      • 8.1.2.8.5 Sweden Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.2.9 Norway
      • 8.1.2.9.1 Key Country Dynamics
      • 8.1.2.9.2 Competitive Scenario
      • 8.1.2.9.3 Regulatory Framework
      • 8.1.2.9.4 Reimbursement Scenario
      • 8.1.2.9.5 Norway Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.1.3 Asia Pacific
      • 8.1.3.1 Asia Pacific Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.3.2 Japan
      • 8.1.3.2.1 Key Country Dynamics
      • 8.1.3.2.2 Competitive Scenario
      • 8.1.3.2.3 Regulatory Framework
      • 8.1.3.2.4 Reimbursement Scenario
      • 8.1.3.2.5 Japan Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.3.3 India
      • 8.1.3.3.1 Key Country Dynamics
      • 8.1.3.3.2 Competitive Scenario
      • 8.1.3.3.3 Regulatory Framework
      • 8.1.3.3.4 Reimbursement Scenario
      • 8.1.3.3.5 India Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.3.4 China
      • 8.1.3.4.1 Key Country Dynamics
      • 8.1.3.4.2 Competitive Scenario
      • 8.1.3.4.3 Regulatory Framework
      • 8.1.3.4.4 Reimbursement Scenario
      • 8.1.3.4.5 China Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.3.5 Australia
      • 8.1.3.5.1 Key Country Dynamics
      • 8.1.3.5.2 8. 6. 3.5competitive Scenario
      • 8.1.3.5.3 Regulatory Framework
      • 8.1.3.5.4 Reimbursement Scenario
      • 8.1.3.5.5 Australia Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.3.6 Thailand
      • 8.1.3.6.1 Key Country Dynamics
      • 8.1.3.6.2 Competitive Scenario
      • 8.1.3.6.3 Regulatory Framework
      • 8.1.3.6.4 Reimbursement Scenario
      • 8.1.3.6.5 Thailand Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.3.7 South Korea
      • 8.1.3.7.1 Key Country Dynamics
      • 8.1.3.7.2 Competitive Scenario
      • 8.1.3.7.3 Regulatory Framework
      • 8.1.3.7.4 Reimbursement Scenario
      • 8.1.3.7.5 South Korea Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.1.4 Latin America
      • 8.1.4.1 Latin America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.4.2 Brazil
      • 8.1.4.2.1 Key Country Dynamics
      • 8.1.4.2.2 Competitive Scenario
      • 8.1.4.2.3 Regulatory Framework
      • 8.1.4.2.4 Reimbursement Scenario
      • 8.1.4.2.5 Brazil Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.4.3 Mexico
      • 8.1.4.3.1 Key Country Dynamics
      • 8.1.4.3.2 Competitive Scenario
      • 8.1.4.3.3 Regulatory Framework
      • 8.1.4.3.4 Reimbursement Scenario
      • 8.1.4.3.5 Mexico Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.4.4 Argentina
      • 8.1.4.4.1 Key Country Dynamics
      • 8.1.4.4.2 Competitive Scenario
      • 8.1.4.4.3 Regulatory Framework
      • 8.1.4.4.4 Reimbursement Scenario
      • 8.1.4.4.5 Argentina Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.1.5 MEA
      • 8.1.5.1 MEA Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.5.2 South Africa
      • 8.1.5.2.1 Key Country Dynamics
      • 8.1.5.2.2 Competitive Scenario
      • 8.1.5.2.3 Regulatory Framework
      • 8.1.5.2.4 Reimbursement Scenario
      • 8.1.5.2.5 South Africa Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.5.3 Saudi Arabia
      • 8.1.5.3.1 Key Country Dynamics
      • 8.1.5.3.2 Competitive Scenario
      • 8.1.5.3.3 Regulatory Framework
      • 8.1.5.3.4 Reimbursement Scenario
      • 8.1.5.3.5 Saudi Arabia Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.5.4 UAE
      • 8.1.5.4.1 Key Country Dynamics
      • 8.1.5.4.2 Competitive Scenario
      • 8.1.5.4.3 Regulatory Framework
      • 8.1.5.4.4 Reimbursement Scenario
      • 8.1.5.4.5 UAE Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.1.5.5 Kuwait
      • 8.1.5.5.1 Key Country Dynamics
      • 8.1.5.5.2 Competitive Scenario
      • 8.1.5.5.3 Regulatory Framework
      • 8.1.5.5.4 Reimbursement Scenario
      • 8.1.5.5.5 Kuwait Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Competitive Market Entry Strategies
  • 9.3. Private Companies/ Vendors, By Country/Region
  • 9.4. Company Market Share Analysis, 2023
  • 9.5. Strategy Mapping
  • 9.6. Company Profiles/Listing
    • 9.6.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 9.6.1.1. Overview
      • 9.6.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Strategic Initiatives
    • 9.6.2. Hamamatsu Photonics, Inc
      • 9.6.2.1. Overview
      • 9.6.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Strategic Initiatives
    • 9.6.3. Koninklijke Philips N.V.
      • 9.6.3.1. Overview
      • 9.6.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Strategic Initiatives
    • 9.6.4. Olympus Corporation
      • 9.6.4.1. Overview
      • 9.6.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Strategic Initiatives
    • 9.6.5. F. Hoffmann-La Roche Ltd
      • 9.6.5.1. Overview
      • 9.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Strategic Initiatives
    • 9.6.6. Mikroscan Technologies, Inc
      • 9.6.6.1. Overview
      • 9.6.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Strategic Initiatives
    • 9.6.7. Inspirata, Inc.
      • 9.6.7.1. Overview
      • 9.6.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Strategic Initiatives
    • 9.6.8. Epredia (3DHISTECH Ltd.)
      • 9.6.8.1. Overview
      • 9.6.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Strategic Initiatives
    • 9.6.9. Visiopharm A/S
      • 9.6.9.1. Overview
      • 9.6.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Strategic Initiatives
    • 9.6.10. Huron Technologies International Inc.
      • 9.6.10.1. Overview
      • 9.6.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Strategic Initiatives
    • 9.6.11. ContextVision AB
      • 9.6.11.1. Overview
      • 9.6.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Strategic Initiatives
    • 9.6.12. CellaVision
      • 9.6.12.1. Overview
      • 9.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.12.3. Product Benchmarking
      • 9.6.12.4. Strategic Initiatives
    • 9.6.13. Hangzhou Zhiwei Information Technology Co. Ltd. (Morphogo)
      • 9.6.13.1. Overview
      • 9.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.13.3. Product Benchmarking
      • 9.6.13.4. Strategic Initiatives
    • 9.6.14. West Medica Produktions- und Handels- GmbH (West Medica)
      • 9.6.14.1. Overview
      • 9.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.14.3. Product Benchmarking
      • 9.6.14.4. Strategic Initiatives
    • 9.6.15. aetherAI
      • 9.6.15.1. Overview
      • 9.6.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.15.3. Product Benchmarking
      • 9.6.15.4. Strategic Initiatives
    • 9.6.16. Ibex (Ibex Medical Analytics)
      • 9.6.16.1. Overview
      • 9.6.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.16.3. Product Benchmarking
      • 9.6.16.4. Strategic Initiatives
    • 9.6.17. SigTuple Technologies Private Limited
      • 9.6.17.1. Overview
      • 9.6.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.17.3. Product Benchmarking
      • 9.6.17.4. Strategic Initiatives
    • 9.6.18. Morphle Labs, Inc
      • 9.6.18.1. Overview
      • 9.6.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.18.3. Product Benchmarking
      • 9.6.18.4. Strategic Initiatives
    • 9.6.19. Bionovation Biotech, Inc
      • 9.6.19.1. Overview
      • 9.6.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.19.3. Product Benchmarking
      • 9.6.19.4. Strategic Initiatives